Clinical Trials Logo

Clinical Trial Summary

This study is being conducted to evaluate the effects of supratherapeutic ETX2514 plasma concentrations on the heart rate-corrected QT interval (QTc).


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms

  • Acinetobacter Baumannii-calcoaceticus Complex Infections
  • Infection

NCT number NCT03985410
Study type Interventional
Source Entasis Therapeutics
Contact
Status Completed
Phase Phase 1
Start date May 23, 2019
Completion date July 24, 2019

See also
  Status Clinical Trial Phase
Completed NCT04018950 - Study to Determine the Excretion and Metabolism of 14C-ETX2514 Administered Intravenously in Healthy Male Subjects Phase 1